DGAP-News

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports fourth quarter and full year 2014 results

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Schlagwort(e):
Jahresergebnis
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports
fourth quarter and full year 2014 results

25.02.2015 / 07:42

---------------------------------------------------------------------

February 25, 2015

INVESTOR NEWS

Fresenius Medical Care reports
fourth quarter and full year 2014 results


- Targets achieved for fiscal year 2014

- Further expansion of our operations and new record level of revenue

- Increased dividend to be proposed at the Annual General Meeting

- Accelerated earnings growth expected

Fourth quarter 2014 key figures:
Net revenue $4,320 million +12%
Operating income (EBIT) $663 million 0%
Net income1 $335 million -4%
Basic earnings per ordinary share $1.11 -5%

Full year 2014 key figures:
Net revenue $15,832 million +8%
Operating income (EBIT) $2,255 million 0%
Net income1 $1,045 million -6%
Basic earnings per ordinary share $3.46 -5%

Dividend proposal:

Ordinary share EUR0.78 +1%

Rice Powell, chief executive officer of Fresenius Medical Care stated:
"During fiscal year 2014, we continuously improved our results and
delivered on revenue and net income guidance. We have strengthened our core
business and also expanded our portfolio with acquisitions in the field of
Care Coordination. After revenue of approximately 500 million US$ in 2013
we now expect our Care Coordination business to generate around 1.7 billion
of revenue in 2015. We expect accelerated earnings growth for 2015 and
beyond supported mainly by a strong organic business, our acquisitions and
the Global Efficiency Program".

Fourth quarter 2014

Revenue

Net revenue for the fourth quarter of 2014 increased by 12% to $4,320
million (+15% at constant currency) as compared to the fourth quarter of
2013. Organic revenue growth worldwide was 7%. Health Care revenue grew by
15% to $3,322 million (+18% at constant currency) and dialysis product
revenue increased by 3% to $998 million (+8% at constant currency) as
compared to the fourth quarter of 2013.

North America revenue for the fourth quarter of 2014 increased by 15% to
$2,876 million. Organic revenue growth was 6%. Health Care revenue grew by
15% to $2,640 million with a same market treatment growth of 4%. Net
Dialysis Care revenue increased by 5% to $2,245 million. Care Coordination